JSE firms amid tech stock losses and Covid-19 vaccine setback
Some investors see the latest downturn as a healthy correction after several of the tech giants reached staggering heights, one analyst says
BL PREMIUM
09 September 2020 – 12:41
The JSE was firmer on Wednesday along with European markets, as investors shrug off concerns over tech stocks losses and a Covid-19 vaccine candidate.
European shares shrugged off heavy losses for US tech stocks on Wednesday, while major drugmaker AstraZeneca delayed testing of a possible coronavirus vaccine, Reuters reported.
Source: businesslive.co.za
